Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael J Crowther
Affiliation
8University of Leicester
ORCID
Career Start Year
2012
Papers
51
H Index
23
Expertise
CM4AI Collaborator
Sarah J Ratcliffe (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37038100
Exploring different research questions via complex multi-state models when using registry-based repeated prescriptions of antidepressants in women with breast cancer and a matched population comparison group.
BMC Med Res Methodol
2023
35044255
Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network.
Stat Methods Med Res
2022
33469974
Multiple imputation strategies for a bounded outcome variable in a competing risks analysis.
Stat Med
2021
33710334
Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival.
Blood Adv
2021
33813933
Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial-Based Cost-Effectiveness Data.
Med Decis Making
2021
33556998
A multistate model incorporating estimation of excess hazards and multiple time scales.
Stat Med
2021
35079747
INTEREST: INteractive Tool for Exploring REsults from Simulation sTudies.
J Data Sci Stat Vis
2021
34837946
Development of a dynamic interactive web tool to enhance understanding of multi-state model analyses: MSMplus.
BMC Med Res Methodol
2021
34006026
Assessing relative COVID-19 mortality: a Swiss population-based study.
BMJ Open
2021
33430778
Relaxing the assumption of constant transition rates in a multi-state model in hospital epidemiology.
BMC Med Res Methodol
2021
32426746
Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial.
Crit Care Explor
2020
31894164
Mixed-effects models for health care longitudinal data with an informative visiting process: A Monte Carlo simulation study.
Stat Neerl
2020
32073229
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study.
J Thromb Haemost
2020
32165717
Jointly modelling longitudinally measured urinary human chorionic gonadotrophin and early pregnancy outcomes.
Sci Rep
2020
30499863
Changes in Body Mass Index and Rates of Death and Transplant in Hemodialysis Patients: A Latent Class Joint Modeling Approach.
Epidemiology
2019
31328285
Impact of model misspecification in shared frailty survival models.
Stat Med
2019
30378472
Joint longitudinal and time-to-event models for multilevel hierarchical data.
Stat Methods Med Res
2019
30652356
Using simulation studies to evaluate statistical methods.
Stat Med
2019
30562050
Donor Lung Sequence Number and Survival after Lung Transplantation in the United States.
Ann Am Thorac Soc
2019
30664613
Measuring and Analyzing Length of Stay in Critical Care Trials.
Med Care
2019
27114326
Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.
Stat Methods Med Res
2018
29701996
An Alternative Approach for the Analysis of Time-to-Event and Survival Outcomes in Pulmonary Medicine.
Am J Respir Crit Care Med
2018
29020167
Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic Status.
Am J Epidemiol
2018
25416688
Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method.
Stat Methods Med Res
2017
28353690
Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma.
Invest Ophthalmol Vis Sci
2017
28851772
Determining the sample size required to establish whether a medical device is non-inferior to an external benchmark.
BMJ Open
2017
28872690
Parametric multistate survival models: Flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences.
Stat Med
2017
28633324
Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.
Am J Epidemiol
2017
27910122
One-stage individual participant data meta-analysis models: estimation of treatment-covariate interactions must avoid ecological bias by separating out within-trial and across-trial information.
Stat Med
2017
28008649
Flexible parametric modelling of the cause-specific cumulative incidence function.
Stat Med
2017
27629911
Analysis of urinary human chorionic gonadotrophin concentrations in normal and failing pregnancies using longitudinal, Cox proportional hazards and two-stage modelling.
Ann Clin Biochem
2017
26864674
Using electronic health records to predict costs and outcomes in stable coronary artery disease.
Heart
2016
26514596
Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.
Stat Med
2016
27042338
Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER).
Eur Heart J Qual Care Clin Outcomes
2016
27027882
Joint longitudinal hurdle and time-to-event models: an application related to viral load and duration of the first treatment regimen in patients with HIV initiating therapy.
Stat Med
2016
24634327
Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.
Stat Med
2015
26434359
Reply to Letter to the Editor by Remontet et al.
Stat Med
2015
26032839
Responses to discussants of 'Joint modeling of survival and longitudinal non-survival data: current methods and issues. report of the DIA Bayesian joint modeling working group'.
Stat Med
2015
25634033
Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
Health Technol Assess
2015
25752749
Setting benchmark revision rates for total hip replacement: analysis of registry evidence.
BMJ
2015
24449433
Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations.
Med Decis Making
2014
25220693
A general framework for parametric survival analysis.
Stat Med
2014
24789760
Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.
Stat Med
2014
23613458
Simulating biologically plausible complex survival data.
Stat Med
2013
26053655
Using meta-analysis to inform the design of subsequent studies of diagnostic test accuracy.
Res Synth Methods
2013
24289257
Adjusting for measurement error in baseline prognostic biomarkers included in a time-to-event analysis: a joint modelling approach.
BMC Med Res Methodol
2013
22340890
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
Health Technol Assess
2012
22555396
Should relative survival be used with lung cancer data?
Br J Cancer
2012
22443286
Individual patient data meta-analysis of survival data using Poisson regression models.
BMC Med Res Methodol
2012
23037571
Flexible parametric joint modelling of longitudinal and survival data.
Stat Med
2012
1 - 50 of 51
Column Actions
Search
Recommended Authors
Yilin Ning
Duke-NUS Medical School, National University of Singapore
Career Start Year
2016
Number of shared co-authors
0
Yulun Liu
University of Texas Southwestern Medical Center.
Career Start Year
2013
Number of shared co-authors
0
Ming Wang
School of Medicine Case Western Reserve University Cleveland OH USA.
Career Start Year
2011
Number of shared co-authors
0
Andrew J Spieker
Vanderbilt University Medical Center
Career Start Year
2011
Number of shared co-authors
0
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Career Start Year
2010
Number of shared co-authors
0
Lihui Zhao
Feinberg School of Medicine
Career Start Year
2009
Number of shared co-authors
0
Jaeil Ahn
Georgetown University
Career Start Year
2008
Number of shared co-authors
0
Usha Govindarajulu
Center for Biostatistics, Icahn School of Medicine at Mount Sinai
Career Start Year
2006
Number of shared co-authors
0
Jessica G Young
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year
2005
Number of shared co-authors
0
Rebecca A Hubbard
Perelman School of Medicine, The University of Pennsylvania
Career Start Year
2005
Number of shared co-authors
3
Mulugeta Gebregziabher
Ralph H. Johnson Veterans Affairs Healthcare System.
Career Start Year
2004
Number of shared co-authors
0
Sebastien Haneuse
Harvard T.H. Chan School of Public Health
Career Start Year
2004
Number of shared co-authors
0
Donglin Zeng
University of North Carolina
Career Start Year
2004
Number of shared co-authors
1
Jessica K Paulus
Hospital of the University of Pennsylvania
Career Start Year
2003
Number of shared co-authors
0
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year
2003
Number of shared co-authors
0
Qi Long
and Informatics Perelman School of Medicine, University of Pennsylvania
Career Start Year
2003
Number of shared co-authors
1
Qingxia Chen
Vanderbilt University Medical Center
Career Start Year
2002
Number of shared co-authors
1
Gary S Collins
University of Oxford
Career Start Year
2002
Number of shared co-authors
1
Lu Tian
Stanford University
Career Start Year
2001
Number of shared co-authors
0
Ronghui Xu
University of California San Diego
Career Start Year
2000
Number of shared co-authors
0
Tianxi Cai
Harvard T.H. Chan School of Public Health
Career Start Year
1999
Number of shared co-authors
0
Karel G M Moons
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Trecht University
Career Start Year
1997
Number of shared co-authors
0
Manisha Desai
Stanford University
Career Start Year
1997
Number of shared co-authors
1
Dimitris Rizopoulos
Erasmus Medical Center
Career Start Year
1996
Number of shared co-authors
4
Wensheng Guo
University of Pennsylvania Perelman School of Medicine
Career Start Year
1995
Number of shared co-authors
2
George Tomlinson
University Health Network
Career Start Year
1994
Number of shared co-authors
1
Ewout W Steyerberg
Leiden University Medical Center
Career Start Year
1992
Number of shared co-authors
0
Patrick J Heagerty
University of Washington
Career Start Year
1992
Number of shared co-authors
1
Stuart R Lipsitz
Harvard Medical School
Career Start Year
1988
Number of shared co-authors
2
Rebecca A Betensky
New York University.
Career Start Year
1987
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Michael O Harhay
University of Pennsylvania, Perelman School of Medicine
Co-authored papers
4
Alessandro Gasparini
Karolinska Institutet
Co-authored papers
4
Sarah J Ratcliffe (CM4AI)
University of Virginia
Co-authored papers
2
Jason D Christie
University of Pennsylvania Perelman School of Medicine
Co-authored papers
2
Rory Wolfe
Co-authored papers
2
Joseph G Ibrahim
University of North Carolina
Co-authored papers
2
Gary E Weissman
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Christopher Kai-Shun Leung
The University of Hong Kong
Co-authored papers
1
James A Russell
St. Paul's Hospital, University of British Columbia
Co-authored papers
1
Per Hall
Co-authored papers
1
Scott D Halpern
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Robert D Herbert
University of New South Wales
Co-authored papers
1
Leah H Suttner
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Allan J Walkey
Boston University School of Medicine
Co-authored papers
1
Dylan S Small
University of Pennsylvania
Co-authored papers
1
1 - 15